Caminnov is a biotechnoligical company dedicated to creating new tools and drugs. For detection or therapeutic interest, our research team develop single domain antibodies in two distinct domains: the environment and health. Many VHHs are currently in development and patents have been submitted.
Caminnov specializes in the development of the single domain antibodies against small molecules (peptides, chemical molecules, toxins). In partnership with other team, we have developed VHHs against chemicals molecules present in the environment (MW: 170 g/mol) . In addition, we have developed other antibodies directed against low molecular weight toxins (MW: 120 g / mol).
Caminnov has developed many VHHs in the field of inflammation ( Interleukins, GPCRs…). The Company has experience in the development of VHHs in the treatment of a wide range of diseases, including inflammation, immuno-oncology and oncology.